Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Translational Lung Cancer Research

AME Publishing Company · Hong Kong · ISSN 2226-4477
Has APC Verified OA APC waiver Visit journal

Translational Lung Cancer Research is a peer-reviewed english-language open-access journal published by AME Publishing Company in Hong Kong, operating under an open-access model since 2012. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.

Authors are required to pay an article processing charge to publish in Translational Lung Cancer Research; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).

All submissions undergo plagiarism screening before peer review.

Keywords

lung cancer, thoracic oncology, oncology

At a glance

Country
Hong Kong
Primary language
English
License
CC BY-NC-ND
Peer review
Double anonymous peer review
OA since
2012
Review time
17 weeks
Plagiarism check
Yes

ISSN

print
2218-6751
electronic
2226-4477

Frequently asked questions

Is Translational Lung Cancer Research peer-reviewed?
Yes — Translational Lung Cancer Research operates a Double anonymous peer review review process.
Does Translational Lung Cancer Research charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Translational Lung Cancer Research publish?
Translational Lung Cancer Research publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Translational Lung Cancer Research accept?
Translational Lung Cancer Research accepts manuscripts in English.
What is the ISSN of Translational Lung Cancer Research?
ISSN: 2218-6751 (print) · 2226-4477 (electronic).
How do I submit a manuscript to Translational Lung Cancer Research?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Translational Lung Cancer Research?
Average time from submission to publication is approximately 17 weeks.

Similar journals

Other open-access journals in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.

Help us grow the directory

Know an open-access journal we don't list yet?

Add it in under a minute. Each suggestion is reviewed by a human editor.

WhatsApp